CAS: 26388-52-3 - (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-alpha-L-lyxo-hexopyranoside
Formula:C29H28F3NO11
InChI:InChI=1/C29H28F3NO11/c1-10-22(35)14(33-27(40)29(30,31)32)7-17(43-10)44-16-9-28(41,11(2)34)8-13-19(16)26(39)21-20(24(13)37)23(36)12-5-4-6-15(42-3)18(12)25(21)38/h4-6,10,14,16-17,22,35,37,39,41H,7-9H2,1-3H3,(H,33,40)/t10-,14-,16-,17-,22+,28-/m0/s1
- Synonyms:
- 5,12-naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-alpha-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Epirubicin Impurity 5 REF: 4Z-E-144009CAS: 26388-52-3 | - - - | To inquire | Mon 16 Dec 24 | |
N-(Trifluoroacetyl)daunorubicin REF: TR-T786985CAS: 26388-52-3 | - - - | 168.00 €~259.00 € | Fri 17 Jan 25 | |
N-(Trifluoroacetyl)daunorubicin REF: 3D-FT28447CAS: 26388-52-3 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-E-144009
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
N-(Trifluoroacetyl)daunorubicin
Controlled ProductCAS:26388-52-3
Applications Protected Daunorubicin. References Duvvuri, M., et al.: Biochem., 44, 15743 (2005), Zhang, G., et …
Formula:
C29H28F3NO11
Color and Shape:
Neat
Molecular weight:
623.53
Ref: TR-T786985
1mg | 168.00 € | ||
2mg | 236.00 € | ||
2500µg | 259.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
N-(Trifluoroacetyl)daunorubicin
CAS:26388-52-3
N-(Trifluoroacetyl)daunorubicin is a chlorinated, water-soluble derivative of daunorubicin, which is an organic compound. It has …
Formula:
C29H28F3NO11
Purity:
Min. 95%
Molecular weight:
623.53 g/mol
Ref: 3D-FT28447
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |